...be resistant to bamlanivimab, and with no testing technologies available to allow healthcare providers to test individual patients for COVID-19 variants, the potential benefits of using the drug no longer...
...of COVID-19 viral mutations that are resistant to bamlanivimab when administered alone. At this time, there are currently no testing technologies available that enable healthcare providers to test individual patients...
...to ensure all workers are either vaccinated or tested for COVID-19 once a week. Companies that do not comply would face thousands of dollars in fines per employee. Prior to...
...of an evidence-based drug formulary for workers’ compensation claims. The bill prohibits workers’ compensation and occupational disease compensation reimbursements for drugs specified as “not recommended” in the Official Disability Guidelines...
Two companion bills, New Jersey S3984 and New Jersey A1023, were introduced, which would require workers’ comp, PIP, and health insurance coverage for the medical use of cannabis under certain...
On June 24th, Healthesystems attended the Washington’s Workers' Compensation Advisory Committee’s (WCAC) quarterly meeting, which focused on the rise in long-term disability claims. Factors contributing to long-term disability claims include...
The California Division of Workers’ Compensation’s (DWC) Pharmacy and Therapeutics (P&T) Committee will hold a virtual public meeting on October 21st at 12:30 PM PST to discuss a range of...
Illinois House Bill 1256 was introduced, written to restrict reimbursement for custom compound medications to a one-time, seven-day supply, payable only if no commercial equivalent exists and all active ingredients...
...is that the company would cease to operate in its current form and would instead emerge from bankruptcy as a public benefit company (PBC) owned by a trust or similar...
...in per-fill price increased 40.4% overall. While cancer is not the most common condition found in workers’ comp claims, it is prevalent enough that drug trends impacting cancer can make...
The California Workers’ Compensation Institute (CWCI) conducted a review of recently published data from the National Academy of Social Insurance (NASI), which contains comprehensive data on workers’ comp benefits, coverage,...
The California Pharmacy and Therapeutic (P&T) Committee will hold a hybrid meeting on April 16th at 12:30 PM PST to discuss key issues related to the workers' compensation drug formulary....
...the differences between workers’ comp and group health PBMs and the specific value that workers’ comp PBMs bring to the table. Sandy Shtab was one of three panelists, joining Sean...
The Texas Department of Insurance will host a CompCourses webinar on December 11th at 1:00 PM CST, focusing on compliance within the Texas workers' comp system. The webinar will provide...
